Search for: "PFIZER"
Results 1101 - 1120
of 4,626
Sort by Relevance
|
Sort by Date
18 Feb 2020, 2:12 pm
Featured Discussion Topics The capital raising landscape and lessons learned Spotlight on gene and cell therapy as an innovative and evolving technology area Capitalizing on the commercial potential of direct-to-consumer genetic testing Strategies for operationalizing a personalized medicine program at the point of care The promise behind AI for… [read post]
18 Feb 2020, 4:00 am
Pfizer Canada ULC, 2020 FC 1, Mr. [read post]
7 Feb 2020, 12:43 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
6 Feb 2020, 1:39 pm
Shaw recently retired as the Global Ombuds for Pfizer Inc. [read post]
30 Jan 2020, 5:29 am
(based in Tennessee and a subsidiary of Sanofi); Pfizer (based in New York); and GlaxoSmithKline (based in Pennsylvania). [read post]
30 Jan 2020, 5:29 am
(based in Tennessee and a subsidiary of Sanofi); Pfizer (based in New York); and GlaxoSmithKline (based in Pennsylvania). [read post]
24 Jan 2020, 10:24 am
Illinois Average Wholesale Price (AWP) Litigation – In October 2019, the State of Illinois continued its string of successes against pharmaceutical companies for inflated pricing of prescription drugs paid for by the Illinois Medicaid program, reaching a $242 million settlement with more than a dozen drug companies, including Abbott Labs, Aventis, Forest Labs, GSK, Johnson & Johnson, Novartis, Pfizer, and others, for allegedly inflating the “average wholesale price”… [read post]
23 Jan 2020, 10:37 pm
The phosphodiesterases 5 inhibitor medications (PDE5i) seem to arouse the litigation propensities of the lawsuit industry. [read post]
23 Jan 2020, 4:00 am
Pfizer Canada Inc., 2018 FC 443, reversed 2018 FC 956 – The Prothonotary denied a motion on consent for issuance of a protective order on a similar basis as in Live Face on Web. [read post]
14 Jan 2020, 11:14 am
First, internal Pfizer emails and an email response to a drug distributor who inquired if Hospira was marketing the generic version of Adrenalin were not “commercial advertising or promotion. [read post]
13 Jan 2020, 12:04 pm
” The newspaper pointed out that other CR award winners included “the Gap and Nike (famous for using sweatshop workers), tobacco giant Altria (which owns Marlboro cigarettes), big banks including CitiGroup and Goldman Sachs, pharmaceutical giants such as Merck, Pfizer, and Johnson & Johnson, and even carbon-polluting power and oil companies, including XCEL Energy and ConocoPhillips. [read post]
13 Jan 2020, 12:04 am
Topics will include, amongst others: the implications of non-obviousness for follow-on medical innovation (e.g. drug repurposing) after the UK Supreme Court's 2019 decision in Actavis v ICOS; the current and future roles of competition law in controlling drug prices, including an update on Flynn and Pfizer; and the potential effect of Brexit on the trade of medical products. [read post]
10 Jan 2020, 9:32 am
Pfizer Pharmaceuticals, LLC, 730 F.3d 49 (1st Cir. 2013) (holding that district court erred in not applying the “reasonable certainty” test to a discretionary promotion). [read post]
7 Jan 2020, 7:26 am
After Pfizer initiated legal proceedings, Roche de-designated the UK from all relevant patent families. [read post]
2 Jan 2020, 9:25 am
Data examined by healthcare research firm 3 Axis Advisors found that major drug makers including Pfizer Inc, GlaxoSmithKline PLC, and Sanofi SA, Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked prices this week. [read post]
20 Dec 2019, 6:33 am
For example, “in 2014, Pfizer paid for a study of its rheumatoid arthritis drug Xeljanz [tofacitinib],” in which its drug “came out on top,” but the study did not include “the treatment experts consider the most effective. [read post]
11 Dec 2019, 5:24 am
” In Pfizer Inc. v. [read post]
7 Nov 2019, 8:10 pm
Companies declining included Bristol-Myers Squibb, 7.9%; Pfizer, 6.9%; and Bayer AG 4.9%. [read post]
29 Oct 2019, 12:46 pm
Lourdes Delgado-Cheers has been appointed a Global Ombuds at Pfizer and based in Denver. [read post]
4 Oct 2019, 10:59 am
Pfizer, Inc., 457 N.J. [read post]
